Open AccessA case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer
Author(s) -
Kazuyuki Hamada,
Kiyoshi Yoshimura,
Kazuhiko Oshinomi,
Yuya Hirasawa,
Hirotsugu Ariizumi,
Ryotaro Ohkuma,
Midori Shida,
Yutaro Kubota,
Hiroto Matsui,
Tomoyuki Ishiguro,
Takehiko Sambe,
Hiroo Ishida,
Atsushi Horiike,
Satoshi Wada,
Sanju Iwamoto,
Naoki Uchida,
Yoshio Ogawa,
Shinichi Kobayashi,
Takuya Tsunoda
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000028339
Subject(s) - medicine , bladder cancer , montelukast , pembrolizumab , cytotoxic t cell , immune system , cancer , immunology , immunotherapy , antibody , asthma , biochemistry , chemistry , in vitro